Heme utilization by rat liver tryptophan pyrrolase as a screening test for exacerbation of hepatic porphyrias by drugs (original) (raw)
PK 11195 aggravates 3,5-diethoxycarbonyl-1,4-dihydrocollidine-induced hepatic porphyria in rats
Moshe Gavish
Hepatology, 1996
View PDFchevron_right
Stimulation of liver heme oxygenase in hexachlorobenzene-induced hepatic porphyria
Giuseppe Poli
Archives of Toxicology, 1998
View PDFchevron_right
Stimulators and Inhibitors of Hepatic Porphyrin Formation in Human Sera
Robert Winchester
Journal of Clinical Investigation, 1974
View PDFchevron_right
Tryptophan pyrrolase in heme metabolism
Mohinder Sardana
Biochemical Pharmacology, 1986
View PDFchevron_right
Effects of mifepristone (RU-486) on heme metabolism and cytochromes P -450 in cultured chick embryo liver cells. Possible implications for acute porphyria
ed cable
European Journal of Biochemistry, 1994
View PDFchevron_right
Sn-protoporphyrin suppresses chemically induced experimental hepatic porphyria. Potential clinical implications
George Drummond
Journal of Clinical Investigation, 1985
View PDFchevron_right
Multiple roles of haem in cystathionine β-synthase activity: implications for hemin and other therapies of acute hepatic porphyria
Abdulla Badawy
Bioscience Reports
View PDFchevron_right
Acute hepatic porphyrias: Current diagnosis & management
Karl Anderson
Molecular Genetics and Metabolism, 2019
View PDFchevron_right
Sn-protoporphyrin rapidly and markedly enhances the heme saturation of hepatic tryptophan pyrrolase. Evidence that this synthetic metalloporphyrin increases the functional content of heme in the liver
Mohinder Sardana
Journal of Clinical Investigation, 1985
View PDFchevron_right
Acute Hepatic Porphyria – Minireview
ANDREI VICENTIU EDU
Modern Medicine, 2023
View PDFchevron_right
Porphyria-induced hepatic porphyrinogen carboxy-lyase inhibitor and its interaction with the active site(s) of the enzyme
Silvia C Billi
IUBMB Life, 1999
View PDFchevron_right
Acute hepatic porphyria
Kilian LaFreniere
Definitions, 2020
View PDFchevron_right
Recurrent attacks of acute hepatic porphyria: major role of the chronic inflammatory response in the liver
Constance Delaby
Journal of Internal Medicine, 2018
View PDFchevron_right
Drug-Induced Modulations of Hepatic Heme Metabolism Neurological Consequences
Jennine Lunetta
Annals of the New York Academy of Sciences, 1987
View PDFchevron_right
The decrease in uroporphyrinogen decarboxylase activity induced by ethanol predisposes rats to the development of porphyria and accelerates xenobiotic-triggered porphyria, regardless of hepatic damage
Maria Rios
Brazilian Journal of Medical and Biological Research, 2002
View PDFchevron_right
Porphobilinogen deaminase over-expression in hepatocytes, but not in erythrocytes, prevents accumulation of toxic porphyrin precursors in a mouse model of acute intermittent porphyria
Rafael Enriquez de Salamanca
View PDFchevron_right
Treatment of the Porphyrias: Mechanisms of Action
David Bickers
Journal of Investigative Dermatology, 1981
View PDFchevron_right
Current and innovative emerging therapies for porphyrias with hepatic involvement
Karl Anderson
Journal of Hepatology, 2019
View PDFchevron_right
Liver Transplantation for Acute Intermittent Porphyria: Biochemical and Pathologic Studies of the Explanted Liver
Karl Anderson
Molecular Medicine, 2015
View PDFchevron_right
Hepatocellular carcinoma without cirrhosis: think acute hepatic porphyrias and vice versa
J. Deybach
Journal of Internal Medicine, 2011
View PDFchevron_right
Identification of Human Hepatic Cytochrome P450 Sources of N-alkylprotoporphyrin IX after Interaction with Porphyrinogenic Xenobiotics, Implications for Detection of Xenobiotic-Induced Porphyria in Humans
Richard Van Breemen
Drug Metabolism and Disposition, 2002
View PDFchevron_right
Review: Molecular pathogenesis of hepatic acute porphyrias
Bernard Grandchamp
Journal of Gastroenterology and Hepatology, 1996
View PDFchevron_right
Acute Intermittent Porphyria : Studies of chronic disease, recombinant enzyme therapy and late complications
Eliane Sardh
2008
View PDFchevron_right
An analysis of the porphyrins of normal and cirrhotic human liver and normal bile
mohammed aziz
Clinica Chimica Acta, 1969
View PDFchevron_right
Biochemistry of porphyrins
Harry Dailey
Molecular Aspects of Medicine, 1990
View PDFchevron_right
N-Alkylprotoporphyrin Formation and Hepatic Porphyria in Dogs After Administration of a New Antiepileptic Drug Candidate: Mechanism and Species Specificity
Brigitte Gerin
Toxicological Sciences, 2014
View PDFchevron_right
EXPLORE: A Prospective, Multinational, Natural History Study of Patients with Acute Hepatic Porphyria with Recurrent Attacks
Eliane Sardh
Hepatology
View PDFchevron_right
Hepatocellular Carcinoma in Acute Hepatic Porphyrias: Results from the Longitudinal Study of the U.S. Porphyrias Consortium
Karl Anderson
Hepatology, 2020
View PDFchevron_right
Effects of volatile anaesthetics on heme metabolism in a murine genetic model of Acute Intermittent Porphyria. A comparative study with other porphyrinogenic drugs
Ana Buzaleh
Biochimica et biophysica acta, 2018
View PDFchevron_right
Identification of N-methylprotoporphyrin IX in livers of untreated mice and mice treated with 3,5-diethoxycarbonyl-1,4-dihydrocollidine: Source of the methyl group
Hani Tabba
Archives of Biochemistry and Biophysics, 1981
View PDFchevron_right